Short-term efficacy of cognitive behavioral therapy plus sertraline vs sertraline monotherapy for adolescent depression: A randomized controlled study

Table 1 Subject characteristics in participants with depression, n (%)

Variables	All (n = 100)
Age, years	12 (10.25,14)
Sex
Men	48 (48.0)
Women	52 (52.0)
Obesity	26 (26.0)
Sleep duration, minute, mean ± SD	365.2 ± 64.4
Time in bed, minute, mean ± SD	441.0 ± 56.5

Table 2 Subject characteristics in participants with depression, n (%)

Variables	Study group (n = 50)	Control group (n = 50)	P value
Age, years	12.6 ± 2.3	11 (4)	0.171
	12.5 (11, 14)
Sex			0.689
Men	23 (46.0)	25 (50.0)
Women	27 (54.0)	25 (50.0)
Obesity	15 (30.0)	11 (22.0)	0.197
Sleep duration, minute, mean ± SD	363.8 ± 68.5	366.5 ± 60.7	0.524
Time in bed, minute, mean ± SD	442.6 ± 56.3	439.3 ± 56.7	0.421

Table 3 Comparison of side effects after treatment in two groups of patients, n (%)

Variables	Study group (n = 50)	Control group (n = 50)	P value
Extrapyramidal side effects			0.743
Muscle stiffness	3 (6)	3 (6)
Tremor	1 (2)	2 (4)
Twisting movement	1 (2)	1 (2)
Immobility	2 (4)	1 (2)
Cholinergic side effects			0.239
Dry mouth	3 (6)	4 (8)
Blurred vision	5 (10)	5 (10)
Stuffy nose	4 (8)	3 (6)
Salivation	3 (6)	4 (8)
Constipation	4 (8)	3 (6)